CD274 and neoplasm: Well-recognized biomarkers for gastric cancer are tissue-based assays such as PD-L1, dMMR, and EBV status3,8, which may be difficult to assess in gastric cancer with insufficient tumor biopsy quantity or quality, especially in undifferentiated tumors and those with heterogeneity8.